RESUMEN
A 86-year-old woman became psychotic one day after starting treatment with 800 mg norfloxacin daily. Discontinuation and short-term treatment with haloperidol were followed by rapid disappearance of symptoms within two days. Since 1984, the Netherlands Centre for Monitoring of Adverse Reactions to Drugs received 19 similar reports of which 12 were attributed to norfloxacin, 3 to ofloxacin and 4 to pipemidic acid. The risk appears to be relatively high in the elderly, especially if they have fever, renal dysfunction and a psychiatric history. Lowering the doses may solve this problem provided the bacterial susceptibility is taken into account.
Asunto(s)
Norfloxacino/efectos adversos , Psicosis Inducidas por Sustancias/etiología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antiinfecciosos/efectos adversos , Femenino , Haloperidol/uso terapéutico , Humanos , Masculino , Persona de Mediana Edad , Psicosis Inducidas por Sustancias/tratamiento farmacológicoAsunto(s)
Ecocardiografía Transesofágica/efectos adversos , Síndrome Carcinoide Maligno/etiología , Antineoplásicos Hormonales/uso terapéutico , Humanos , Ketanserina/uso terapéutico , Masculino , Síndrome Carcinoide Maligno/terapia , Persona de Mediana Edad , Octreótido/uso terapéutico , Antagonistas de la Serotonina/uso terapéuticoRESUMEN
Melioidosis is an infectious disease caused by Burkholderia pseudomallei. It is endemic in South East Asia and tropical regions of Northern Australia. Sporadic cases have been described elsewhere. In this article we present a case of acute pulmonary melioidosis with fatal outcome imported from Brazil. The most common pathogen causing severe community-acquired pneumonia in Brazil is Streptococcus pneumoniae. Other possible pathogens include Legionella spp., Mycoplasma pneumonia, Gram-negative rods and viruses. There are few reports of melioidosis in the Americas. This article represents the second known human case of melioidosis from Brazil. Recognition of melioidosis as a possible cause of severe pneumonia, even if a patient has not been travelling in a highly endemic area, is important because of the therapeutic consequences. The epidemiology of melioidosis will be reviewed.